HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of in vivo 'priming' on endotoxin-induced hypotension and tissue injury. The role of PAF and tumor necrosis factor.

Abstract
Exogenously administered tumor necrosis factor-alpha (TNF) and bacterial endotoxin (LPS) induce shock and tissue injury. Here, the authors studied the effect of endogenous TNF on LPS-induced hypotension and tissue injury and investigated the role of PAF in these responses. Rats were primed with intraperitoneal injection of zymosan 24 hours before, or Bacillus Calmette-Guérin (BCG) 12 to 15 days before intravenous injection of low dose (0.5 mg/kg) LPS. It was found that nonprimed animals showed mild hypotension and moderate leukopenia in response to LPS. In contrast, zymosanprimed rats developed shock and marked leukopenia, and more severe bowel injury than nonprimed rats. The authors then showed that, following LPS injection, zymosan-primed animals had higher TNF and platelet-activating factor (PAF) levels than nonprimed rats. Pretreatment of the animal with PAF antagonist, SRI 63-441, markedly ameliorated the hypotension and tissue injury. Interestingly, BCG-primed rats did not show aggravation of LPS-induced hypotension. Only TNF (but not PAF) level in these animals was increased. Thus, it appears that TNF release alone, without a sufficient increase in PAF, is incapable of causing severe hypotension. However, most of the BCG-primed animals showed tissue injury, which could be prevented by pretreatment with PAF antagonist. The authors discuss the possible mechanisms of this discrepancy between systemic and local responses in BCG-primed animals.
AuthorsX M Sun, W Hsueh, G Torre-Amione
JournalThe American journal of pathology (Am J Pathol) Vol. 136 Issue 4 Pg. 949-56 (Apr 1990) ISSN: 0002-9440 [Print] United States
PMID2327475 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • BCG Vaccine
  • Endotoxins
  • Lipopolysaccharides
  • Platelet Activating Factor
  • Quinolinium Compounds
  • Tumor Necrosis Factor-alpha
  • SRI 63-441
  • Zymosan
Topics
  • Animals
  • BCG Vaccine (administration & dosage)
  • Endotoxins (toxicity)
  • Gastrointestinal Diseases (chemically induced, pathology)
  • Hypotension (chemically induced)
  • Lipopolysaccharides (toxicity)
  • Platelet Activating Factor (antagonists & inhibitors, metabolism, pharmacology)
  • Quinolinium Compounds (pharmacology)
  • Rats
  • Rats, Inbred Strains
  • Shock, Septic (physiopathology)
  • Tumor Necrosis Factor-alpha (metabolism, pharmacology)
  • Zymosan (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: